Henderson Jane (CIK 0001422304)

Latest company ownership

Shares held
196,371
Last filed at
Dec 5, 2025
Confidence Score
44.4
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
11,200
Last filed at
Mar 26, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q1 2025Q4
Shares held
3,000
Last filed at
Aug 12, 2025
Confidence Score
44.8
2025Q4
Confidence Score History
2023Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 19, 2025 Dec 23, 2025 Apogee Therapeutics, Inc. CFO Sell 48.8 -1,500 -0.77% ✓ $120K
Dec 4, 2025 Dec 5, 2025 Apogee Therapeutics, Inc. CFO Sell 47.5 -1,500 -0.76% ✓ $112.5K
Nov 25, 2025 Nov 28, 2025 Apogee Therapeutics, Inc. CFO Sell 47.5 -1,500 -0.76% ✓ $105K
Nov 14, 2025 Nov 14, 2025 Apogee Therapeutics, Inc. CFO Sell 45.0 -2,000 -1.00% ✓ $130K
Nov 11, 2025 Nov 13, 2025 Apogee Therapeutics, Inc. CFO Sell 48.8 -1,000 -0.50% ✓ $60K
Aug 12, 2025 Aug 12, 2025 Akero Therapeutics, Inc. Director Sell 22.5 -3,000 -24.20% ✗ $142.4K
Aug 23, 2024 Aug 23, 2024 Apogee Therapeutics, Inc. CFO Sell 20.0 -6,000 -2.90% ✗ $289.6K
Jun 16, 2023 Jun 21, 2023 Akero Therapeutics, Inc. Director Sell 17.5 -40,000 -100.00% ✗ $2.2M
Mar 22, 2018 Mar 26, 2018 Voyager Therapeutics, Inc. CFO Sell 20.0 -31,100 -100.00% ✗ $649.1K
Mar 16, 2018 Mar 20, 2018 Voyager Therapeutics, Inc. CFO Sell 20.0 -17,316 -100.00% ✗ $382.8K